Irvine Skeoch

Chief Operating Officer at CPC Scientific Inc.

Irvine Skeoch is the current Chief Operating Officer at CPC Scientific. Prior to this, they worked as the Executive Director and Leadership Team Member for the Sino-American Pharmaceutical Professionals Association (SAPA-NE) from September 2010 to January 2012. Before that, they were with Lake Capital and CPC Scientific.

Skeoch has been working in the pharmaceutical industry for many years and has been instrumental in promoting communication among scientists, policy makers, government officers, educators, and journalists from both the United States and China. Irvine is committed to fostering career development for members of the SAPA and promoting scientific exchanges and networking opportunities.

Irvine Skeoch received a certificate in Strategic and Conceptual Selling from Miller Heiman and a degree in Pharmaceutical Engineering from Beijing University of Chemical Technology. Irvine also has a Biology degree from Texas A&M University and was an instructor for undergraduate classes there. Irvine is currently a Field Biology Fellow for AUF.

Their manager is Shawn Lee, CEO and Founder. They work with Stuart White - Senior Director of Business Development, East Coast, Chris Gothard - Director of Marketing, and Mandy Ma - Director of QA.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


CPC Scientific Inc.

1 followers

With over 20 years of experience, CPC Scientific is a global CRDMO specializing in peptides and oligonucleotides. Our integrated service model supports partners through critical drug development stages, focusing on late-phase, large-scale, and commercial production. We provide GMP-grade synthetic peptides, oligonucleotides, and peptide-oligonucleotide conjugates, plus a wide range of custom and catalog research products. Our FDA- and ICH-compliant GMP facility ensures regulatory support for IND, NDA, and global filings. We offer process and method development, validation, stability studies, and regulatory documentation to accelerate your program from clinical trials to market. With scalable capacity from milligrams to 100 kilograms, flexible infrastructure, and a robust supply chain, CPC Scientific delivers dependable, high-quality results at every phase, providing the expertise and speed to bring your peptide and oligonucleotide programs to successful commercial production.


Employees

201-500

Links